Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1974 Oct 31;140(5):1303–1316. doi: 10.1084/jem.140.5.1303

STUDIES ON MEDIATOR PRODUCTION BY HIGHLY PURIFIED HUMAN T AND B LYMPHOCYTES

Ross E Rocklin 1, Richard P MacDermott 1, Leonard Chess 1, Stuart F Schlossman 1, John R David 1
PMCID: PMC2139736  PMID: 4608321

Abstract

Highly purified populations of T and B lymphocytes obtained by affinity column separation were stimulated by antigen and their ability to produce two mediators, migration inhibitory factor (MIF) and lymphocyte mitogenic factor (LMF) was assessed. Both T- and B-cell populations made MIF; the production of MIF was antigen-specific using purified protein derivative of tuberculin, streptokinase-streptodornase, and Candida antigens. The MIF activity from both populations could not be attributed to antigen-antibody complexes as the inhibitory activity eluted from Sephadex G-100 columns in the same region corresponding to mol wt 23,000 daltons. Further studies indicate that the T cells producing MIF are proliferating cells whereas the B cells producing this mediator are not. In contrast, LMF was made only by T cells and not B cells when these populations were stimulated by antigen. The LMF induced the [3H]thymidine incorporation into both T and B cells obtained from donors lacking sensitivity to the antigens used to elicit the factor. Chromatographic studies indicate that LMF eluted from Sephadex G-100 in a fraction of mol wt 23,000 daltons where MIF is also found; however, since B cells produce MIF but not LMF, these two factors appear to be distinct from one another. Some of the implications of these findings are discussed. The explanation for the production or lack of production of MIF by lymphocytes obtained from patients with immunodeficiency disorders requires reinterpretation.

Full Text

The Full Text of this article is available as a PDF (841.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Churchill W. H., Rocklin R. R., Moloney W. C., David J. R. In vitro evidence of normal lymphocyte function in some patients with Hodgkin's disease and negative delayed cutaneous hypersensitivity. Natl Cancer Inst Monogr. 1973 May;36:99–106. [PubMed] [Google Scholar]
  2. DAVID J. R., AL-ASKARI S., LAWRENCE H. S., THOMAS L. DELAYED HYPERSENSITIVITY IN VITRO. I. THE SPECIFICITY OF INHIBITION OF CELL MIGRATION BY ANTIGENS. J Immunol. 1964 Aug;93:264–273. [PubMed] [Google Scholar]
  3. David J. R., David R. R. Cellular hypersensitivity and immunity. Inhibition of macrophage migration and the lymphocyte mediators. Prog Allergy. 1972;16:300–449. [PubMed] [Google Scholar]
  4. David J. R. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci U S A. 1966 Jul;56(1):72–77. doi: 10.1073/pnas.56.1.72. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Epstein L. B., Kreth H. W., Herzenberg L. A. Fluorescence-activated cell sorting of human T and B lymphocytes. II. Identification of the cell type responsible for interferon production and cell proliferation in response to mitogens. Cell Immunol. 1974 Jun;12(3):407–421. doi: 10.1016/0008-8749(74)90097-5. [DOI] [PubMed] [Google Scholar]
  6. GEORGE M., VAUGHAN J. H. In vitro cell migration as a model for delayed hypersensitivity. Proc Soc Exp Biol Med. 1962 Nov;111:514–521. doi: 10.3181/00379727-111-27841. [DOI] [PubMed] [Google Scholar]
  7. Geha R. S., Merler E. Human lymphocyte mitogenic factor: synthesis by sensitized thymus-derived lymphocytes, dependence of expression on the presence of antigen. Cell Immunol. 1974 Jan;10(1):86–104. doi: 10.1016/0008-8749(74)90154-3. [DOI] [PubMed] [Google Scholar]
  8. Geha R. S., Schneeberger E., Rosen F. S., Merler E. Interaction of human thymus-derived and non-thymus-derived lymphocytes in vitro. Induction of proliferation and antibody synthesis in B lymphocytes by a soluble factor released from antigen-stimulated T lymphocytes. J Exp Med. 1973 Nov 1;138(5):1230–1247. doi: 10.1084/jem.138.5.1230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kirkpatrick C. H., Rich R. R., Bennett J. E. Chronic mucocutaneous candidiasis: model-building in cellular immunity. Ann Intern Med. 1971 Jun;74(6):955–978. doi: 10.7326/0003-4819-74-6-955. [DOI] [PubMed] [Google Scholar]
  10. Papageorgiou P. S., Henley W. L., Glade P. R. Production and characterization of migration inhibitory factor(s) (MIF) of established lymphoid and non-lymphoid cell lines. J Immunol. 1972 Feb;108(2):494–504. [PubMed] [Google Scholar]
  11. Rocklin R. E., Chilgren R. A., Hong R., David J. R. Transfer of cellular hypersensitivity in chronic mucocutaneous candidiasis monitored in vivo and in vitro. Cell Immunol. 1970 Sep;1(3):290–299. doi: 10.1016/0008-8749(70)90050-x. [DOI] [PubMed] [Google Scholar]
  12. Rocklin R. E., Meyers O. L., David J. R. An in vitro assay for cellular hypersensitivity in man. J Immunol. 1970 Jan;104(1):95–102. [PubMed] [Google Scholar]
  13. Rocklin R. E., Pence H., Kaplan H., Evans R. Cell-mediated immune response of ragweed-sensitive patients to ragweed antigen E. In vitro lymphocyte transformation and elaboration of lymphocyte mediators. J Clin Invest. 1974 Mar;53(3):735–744. doi: 10.1172/JCI107612. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Rocklin R. E. Production of migration inhibitory factor by non-dividing lymphocytes. J Immunol. 1973 Mar;110(3):674–678. [PubMed] [Google Scholar]
  15. Rocklin R. E., Remold H. G., David J. R. Characterization of human migration inhibitory factor (MIF) from antigen-stimulated lymphocytes. Cell Immunol. 1972 Nov;5(3):436–445. doi: 10.1016/0008-8749(72)90070-6. [DOI] [PubMed] [Google Scholar]
  16. Rocklin R. E., Rosen F. S., David J. R. In vitro lymphocyte response of patients with immunologic deficiency diseases. N Engl J Med. 1970 Jun 11;282(24):1340–1343. doi: 10.1056/NEJM197006112822404. [DOI] [PubMed] [Google Scholar]
  17. Spitler L. E., Levin A. S., Stites D. P., Fudenberg H. H., Pirofsky B., August C. S., Stiehm E. R., Hitzig W. H., Gatti R. A. The Wiskott-Aldrich syndrome. Results of transfer factor therapy. J Clin Invest. 1972 Dec;51(12):3216–3224. doi: 10.1172/JCI107148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Tsuchimoto T., Tubergen D. G., Bloom A. D. Synthesis of macrophage migration inhibition factor (MIF) by immunoglobulin-producing lymphocyte lines and their clones. J Immunol. 1972 Oct;109(4):884–886. [PubMed] [Google Scholar]
  19. Valentine F. T., Lawrence H. S. Lymphocyte stimulation: transfer of cellular hypersensitivity to antigen in vitro. Science. 1969 Sep 5;165(3897):1014–1016. doi: 10.1126/science.165.3897.1014. [DOI] [PubMed] [Google Scholar]
  20. Yoshida T., Sonozaki H., Cohen S. The production of migration inhibition factor by B and T cells of the guinea pig. J Exp Med. 1973 Oct 1;138(4):784–797. doi: 10.1084/jem.138.4.784. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES